Cancer Research Institute

This Institute was formally established by the Board of Trustees in June 2001. Its goal is to create an environment that represents the full spectrum of cancer research and to provide opportunities for collaborative research and multidisciplinary training.

The Institute has three divisions: Cancer Biology and Genetics, which includes the Cancer Research Laboratories plus investigators with a primary focus on Cancer Genetics; Cancer Clinical Trials, which includes the Canadian Cancer Trials Group or CCTG (formerly NCIC Clinical Trials Group); and Cancer Care and Epidemiology, which includes the Radiation Oncology Research Unit plus investigators with a primary interest in environmental causes of cancer.

The three divisions are supported by a large number of faculty, graduate and post-doctoral trainees and support staff.

Becoming the Sinclair Cancer Research Institute

A transformational gift in 2024 is significantly advancing cancer research at Queen’s. With support from Murray (Com’84) and Cara Sinclair, the university is building research capacity in an area of existing strength, establish advanced facilities, create training opportunities, and work to improve cancer care and treatments locally, nationally, and around the world. 

In recognition of their $25 million contribution, the Queen’s Cancer Research Institute (QCRI) was renamed the Cara and Murray Sinclair Cancer Research Institute (SCRI). 

Lean more about the Sinclair Cancer Research Institute...